EP-066 - MIELOTOXICIDADE PELO USO DE PIPERACILINA-TAZOBACTAM

EP-066 - MIELOTOXICIDADE PELO USO DE PIPERACILINA-TAZOBACTAM

Introdução: Os Beta-lactâmicos (BL) são amplamente usados contra bactérias, as quais podem ter resistência por meio da produção de Beta-lactamase. Para isso dispõe-se de Beta-lactâmicos + Inibidor da Beta-lactamase: a Piperacilina-Tazobactam, por exemplo, inibe a enzima que degrada o BL. Dentre as r...

Full description

Saved in:

Bibliographic Details
Main Authors:	Antonio Sérgio Mathias, Larissa de Pontes Silva, Livia Fratelli, Caroline Costa Tuma, Victoria M. Bernardes, Henrique Bulgarelli Dora, Pedro Henrique Gregio Cazanova, Arthur L.E. de F. Silva, Valéria de M. Silveira Telles, Francini Guerra Corrêa
Format:	Article
Language:	English
Published:	Elsevier 2024-10-01
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867024002757
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tazobactam selects for multidrug resistance
by: Emma R. Holden, et al.
Published: (2025-05-01)

PE-066 Impacto econômico da central de diluição de medicamentos em terapias antimicrobianas
by: Lucas Vinicius Silva Oliveira, et al.
Published: (2025-03-01)

The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa
by: Aviv Barzilai, et al.
Published: (2024-12-01)

Piperacillin-tazobactam: prospects for use in real-world practice
by: Yu. M. Gomon
Published: (2023-10-01)

Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis
by: Aikaterini Kyriakou, et al.
Published: (2019-01-01)

EP-038 - COINFECÇÃO NEUROCRIPTOCOCOSE, PARACOCCIDIOIDOMICOSE CUTÂNEA E CITOMEGALOVIROSE DISSEMINADA EM PACIENTE COM HIV-AIDS: RELATO DE CASO
by: Giovana Sapienza Muro, et al.
Published: (2024-10-01)

P066: Treatment of BOLA3-associated multiple mitochondrial dysfunctions syndrome 2 with a mitochondrial cocktail
by: Ryan Peretz, et al.
Published: (2025-01-01)

Use of Ceftolozane/Tazobactam in a Case of Septic Shock by Puerperal Sepsis
by: Mario Pezzi, et al.
Published: (2019-01-01)

EP-002 - MANIFESTAÇÕES NEUROLÓGICAS EM VIGÊNCIA DE INFECÇÃO PELO VÍRUS CHIKUNGUNYA: UMA SÉRIE DE CASOS
by: Alice Tobal Verro, et al.
Published: (2024-10-01)

ID066 Formação inovadora em Economia e Avaliação de Tecnologias em Saúde no Brasil: monitoramento do MBA do Hospital Alemão Oswaldo Cruz
by: Livia Fernandes Probst, et al.
Published: (2024-11-01)

Influência do exercício físico nas alterações cardiovasculares induzidas pelo hipotireoidismo
by: Alesandra Araújo de Souza, et al.
Published: (2013-04-01)

Treatment of Polymicrobial Osteomyelitis with Ceftolozane-Tazobactam: Case Report and Sensitivity Testing of Isolates
by: Jeffrey C. Jolliff, et al.
Published: (2016-01-01)

Mechanisms of ceftolozane/tazobactam resistance in Pseudomonas aeruginosa isolates from South Korea
by: Yu Mi Wi, et al.
Published: (2024-12-01)

Abstract 066: Mechanical Thrombectomy Access in Africa: A Mission Thrombectomy (MT‐2020 Plus) MT‐GLASS Study Sub‐Analysis
by: Gabriela Alejo, et al.
Published: (2023-11-01)

Comparison of the effect of carbapenem and piperacillin-tazobactam on the development of fecal colonization with carbapenem resistant Enterobacterales
by: Tuğba Pamukçu, et al.
Published: (2024-12-01)

Compliance of extended infusion of piperacillin/tazobactam with the desired pharmacokinetic/pharmacodynamic index in septic patients
by: Tomić Nataša, et al.
Published: (2025-01-01)

Etnoespécies vegetais utilizadas pelo povo xukuru do ororubá para fins medicinais
by: Gyselle Tenório Guênes, et al.
Published: (2024-12-01)

Glasgow coma scale pupil score (GCS-P) and the hospital mortality in severe traumatic brain injury: analysis of 1,066 Brazilian patients
by: Melina Moré Bertotti, et al.
Published: (2023-05-01)

Reliability of various antimicrobial susceptibility testing methods for piperacillin/tazobactam in challenging Escherichia coli isolates
by: Faruk Demirocak, et al.
Published: (2025-03-01)

In vitro activity of ceftolozane/tazobactam against ESBL-producing enterobacterales in China: SMART 2016–2019
by: Wei Yu, et al.
Published: (2025-05-01)

Activity of ceftolozane/tazobactam against commonly encountered antimicrobial resistant Gram-negative bacteria in Lebanon
by: George F Araj, et al.
Published: (2020-06-01)

Use of Ceftolozane-Tazobactam in Patient with Severe Medium Chronic Purulent Otitis by XDR Pseudomonas aeruginosa
by: L. M. Saraca, et al.
Published: (2019-01-01)

Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis.
by: Hui Yang, et al.
Published: (2015-01-01)

Irradiation Effects on Microstructure and Dielectric Properties of Ba[(Mg0.32Co0.02)Nb0.66]O3 [BMCN] Thin Films
by: N.V. Patel, et al.
Published: (2012-12-01)

Os partidos políticos envolvidos na disputa pelo reconhecimento das famílias homoparentais
by: Claudio Henrique Miranda Horst
Published: (2018-11-01)

A (im)possibilidade de contratação de ex-detentos pelo poder público
by: Carlos Henrique Pereira Alcântara
Published: (2024-07-01)

A EDUCAÇÃO FÍSICA NO PROGRAMA DE EDUCAÇÃO PELO TRABALHO PARA A SAÚDE DE CUIABÁ-MT
by: Valdemar Guedes da Silva, et al.
Published: (2012-09-01)

Ceftazidime-Induced Overexpression of MexJK-OprM Confers Resistance to Ceftolozane/Tazobactam in an Isolate of Pseudomonas aeruginosa
by: Sato T, et al.
Published: (2025-08-01)

Comparative outcomes of Piperacillin-Tazobactam versus Ceftriaxone in managing spontaneous bacterial peritonitis in cirrhotic patients: An observational study
by: Azhar Hussain, et al.
Published: (2025-06-01)

Frequency of Acute Kidney Injury in Patient Receiving Piperacillin - Tazobactam: A Hospital-based Study from Qatar
by: Fahmi Yousef Khan, et al.
Published: (2021-07-01)

Collateral susceptibility-guided alternation of ceftolozane/tazobactam with imipenem prevents resistance development in XDR Pseudomonas aeruginosa biofilms
by: María Fernández-Billón, et al.
Published: (2024-12-01)

A arte pelo homem
by: Medeiros, José A. Fogaça de
Published: (1969-01-01)

Structural, Optical, and Dielectric Properties of A[(Mg0.32Co0.02) Nb0.66]O3 Semiconductor, Where (a = Ba, Sr or Ca)
by: R. Kumar, et al.
Published: (2011-01-01)

Assessment of in vitro antimicrobial activities of ceftolozane/tazobactam and ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates
by: Dalia Salem, et al.
Published: (2025-04-01)

Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
by: M. Mieresova, et al.
Published: (2023-03-01)

Suitability of Piperacillin–Tazobactam for Treating Dogs Infected with Extended-Spectrum β-Lactamase-Producing Enterobacterales: Pharmacokinetic and Pharmacodynamic Analysis
by: Kazuki Harada, et al.
Published: (2025-04-01)

Interdisciplinary Team Pilot to Reduce Time to Administration of Piperacillin/Tazobactam in the Emergency Department at a Veterans Affairs Medical Center
by: DiVittorio MM, et al.
Published: (2025-02-01)

Predictive Modelling of nephrotoxicity from vancomycin and piperacillin-tazobactam (VPT) combination and vancomycin as monotherapy: an artificial intelligence (AI) Approach
by: Dr Winnie Lee, et al.
Published: (2025-03-01)

INFORMAÇÃO E PLANEJAMENTO CORPORATIVO: A CONSULTORA DELOITTE E SUAS ARTICULAÇÕES NO TERRITÓRIO BRASILEIRO
by: Sérgio Henrique de Oliveira Teixeira, et al.
Published: (2019-12-01)

EP-184 - PREVALÊNCIA DE SÍFILIS E FATORES ASSOCIADOS EM UNIVERSITÁRIOS DO ESTADO DA PARAÍBA
by: Ana Cristina De Oliveira E Silva, et al.
Published: (2024-10-01)